27896225|t|The Urokinase / Urokinase Receptor System in Mast Cells: Effects of its Functional Interaction with fMLF Receptors
27896225|a|Mast cell and basophils express the high affinity receptor for IgE (FcɛRI) and are primary effector cells of allergic disorders. The urokinase (uPA)-mediated plasminogen activation system is involved in physiological and pathological events based on cell migration and tissue remodelling, such as inflammation, wound healing, angiogenesis and metastasis. uPA is a serine protease that binds uPAR, a high affinity glycosyl-phosphatidyl-inositol (GPI)-anchored receptor. uPAR focuses uPA activity at the cell surface and activates intracellular signaling through lateral interactions with integrins, receptor tyrosine kinases and the G-protein-coupled family of fMLF chemotaxis receptors (FPRs). We investigated the expression of the uPA - uPAR system and its functional interaction with FPRs in human mast cells (MCs). Differently from basophils, MCs produced uPA that was able to induce their chemotaxis. Indeed, MCs also expressed uPAR, both in the intact and in a cleaved form (DII-DIII-uPAR) that can expose, at the N-terminus, the SRSRY sequence, able to interact with FPRs and to mediate cell chemotaxis. MCs also expressed mRNAs for FPRs that were functionally active; indeed, uPA and a soluble peptide (uPAR84-95), containing the SRSRY chemotactic sequence of uPAR and able to interact with FPRs, were able to induce MCs chemotaxis. Thus, uPA is a potent chemoattractant for MCs acting through the exposure of the chemotactic epitope of uPAR, that is an endogenous ligand for FPRs. The same mechanism could be involved in VEGF-A secretion by human MCs, also induced by uPA and uPAR84-95 stimulation.
27896225	4	13	Urokinase	T116,T121,T126	C0042071
27896225	16	34	Urokinase Receptor	T116,T129,T192	C0071216
27896225	45	55	Mast Cells	T025	C0024880
27896225	57	64	Effects	T080	C1280500
27896225	72	82	Functional	T169	C0205245
27896225	83	94	Interaction	T169	C1704675
27896225	100	114	fMLF Receptors	T116,T192	C0597357
27896225	115	124	Mast cell	T025	C0024880
27896225	129	138	basophils	T025	C0004827
27896225	139	146	express	T045	C0597360
27896225	151	173	high affinity receptor	T116,T192	C0597357
27896225	178	181	IgE	T116,T129	C0020846
27896225	183	188	FcɛRI	T116,T129	C0020846
27896225	198	220	primary effector cells	T025	C0312740
27896225	224	242	allergic disorders	T046	C0020517
27896225	248	257	urokinase	T116,T121,T126	C0042071
27896225	259	262	uPA	T116,T121,T126	C0042071
27896225	273	302	plasminogen activation system	T044	C1622667
27896225	318	331	physiological	T039	C0031845
27896225	336	355	pathological events	T046	C0030660
27896225	365	379	cell migration	T043	C1622501
27896225	384	402	tissue remodelling	T042	C1254358
27896225	412	424	inflammation	T046	C0021368
27896225	426	439	wound healing	T040	C0043240
27896225	441	453	angiogenesis	T042	C0302600
27896225	458	468	metastasis	T046	C4255448
27896225	470	473	uPA	T116,T121,T126	C0042071
27896225	479	494	serine protease	T116,T126	C2717971
27896225	506	510	uPAR	T116,T129,T192	C0071216
27896225	514	573	high affinity glycosyl-phosphatidyl-inositol (GPI)-anchored	T109,T123	C0119748
27896225	574	582	receptor	T116,T192	C0597357
27896225	584	588	uPAR	T116,T129,T192	C0071216
27896225	597	600	uPA	T116,T121,T126	C0042071
27896225	601	609	activity	T044	C0243102
27896225	617	629	cell surface	T026	C0699040
27896225	634	667	activates intracellular signaling	T044	C3822614
27896225	684	696	interactions	T169	C1704675
27896225	702	711	integrins	T116,T129,T192	C0021701
27896225	713	738	receptor tyrosine kinases	T116,T126,T192	C0206364
27896225	747	771	G-protein-coupled family	T116,T126	C0872043
27896225	775	800	fMLF chemotaxis receptors	T116,T192	C0597357
27896225	802	806	FPRs	T116,T192	C0597357
27896225	812	824	investigated	T169	C1292732
27896225	829	839	expression	T045	C1171362
27896225	847	850	uPA	T116,T121,T126	C0042071
27896225	853	857	uPAR	T116,T129,T192	C0071216
27896225	873	883	functional	T169	C0205245
27896225	884	895	interaction	T169	C1704675
27896225	901	905	FPRs	T116,T192	C0597357
27896225	909	914	human	T016	C0086418
27896225	915	925	mast cells	T025	C0024880
27896225	927	930	MCs	T025	C0024880
27896225	950	959	basophils	T025	C0004827
27896225	961	964	MCs	T025	C0024880
27896225	974	977	uPA	T116,T121,T126	C0042071
27896225	1008	1018	chemotaxis	T043	C0008018
27896225	1028	1031	MCs	T025	C0024880
27896225	1047	1051	uPAR	T116,T129,T192	C0071216
27896225	1095	1108	DII-DIII-uPAR	T116,T129,T192	C0071216
27896225	1150	1164	SRSRY sequence	T087	C0002518
27896225	1188	1192	FPRs	T116,T192	C0597357
27896225	1208	1223	cell chemotaxis	T043	C2610454
27896225	1225	1228	MCs	T025	C0024880
27896225	1244	1249	mRNAs	T114,T123	C0035696
27896225	1254	1258	FPRs	T116,T192	C0597357
27896225	1298	1301	uPA	T116,T121,T126	C0042071
27896225	1308	1323	soluble peptide	T116	C0030956
27896225	1325	1334	uPAR84-95	T116,T129,T192	C0071216
27896225	1352	1378	SRSRY chemotactic sequence	T087	C0002518
27896225	1382	1386	uPAR	T116,T129,T192	C0071216
27896225	1413	1417	FPRs	T116,T192	C0597357
27896225	1439	1442	MCs	T025	C0024880
27896225	1443	1453	chemotaxis	T043	C0008018
27896225	1461	1464	uPA	T116,T121,T126	C0042071
27896225	1477	1492	chemoattractant	T123	C0008013
27896225	1497	1500	MCs	T025	C0024880
27896225	1520	1528	exposure	T080	C0332157
27896225	1536	1547	chemotactic	T043	C0008018
27896225	1548	1555	epitope	T129	C0003316
27896225	1559	1563	uPAR	T116,T129,T192	C0071216
27896225	1576	1586	endogenous	T169	C0205227
27896225	1587	1593	ligand	T103	C0023688
27896225	1598	1602	FPRs	T116,T192	C0597357
27896225	1613	1622	mechanism	T169	C0441712
27896225	1644	1650	VEGF-A	T116,T123	C0078058
27896225	1651	1660	secretion	T038	C0036536
27896225	1664	1669	human	T016	C0086418
27896225	1670	1673	MCs	T025	C0024880
27896225	1680	1687	induced	T169	C0205263
27896225	1691	1694	uPA	T116,T121,T126	C0042071
27896225	1699	1708	uPAR84-95	T116,T129,T192	C0071216
27896225	1709	1721	stimulation.	T044	C1148560